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Abstract
Background:  In recent years, considerable knowledge has been gained on the molecular
mechanisms underlying retinal cell fate specification. However, hitherto studies focused primarily
on the six major retinal cell classes (five types of neurons of one type of glial cell), and paid little
attention to the specification of different neuronal subtypes within the same cell class. In particular,
the molecular machinery governing the specification of the two most abundant neurotransmitter
phenotypes in the retina, GABAergic and glutamatergic, is largely unknown. In the spinal cord and
cerebellum, the transcription factor Ptf1a is essential for GABAergic neuron production. In the
mouse retina, Ptf1a has been shown to be involved in horizontal and most amacrine neurons
differentiation.
Results: In this study, we examined the distribution of neurotransmitter subtypes following Ptf1a
gain and loss of function in the Xenopus retina. We found cell-autonomous dramatic switches
between GABAergic and glutamatergic neuron production, concomitant with profound defects in
the genesis of amacrine and horizontal cells, which are mainly GABAergic. Therefore, we
investigated whether Ptf1a promotes the fate of these two cell types or acts directly as a
GABAergic subtype determination factor. In ectodermal explant assays, Ptf1a was found to be a
potent inducer of the GABAergic subtype. Moreover, clonal analysis in the retina revealed that
Ptf1a overexpression leads to an increased ratio of GABAergic subtypes among the whole amacrine
and horizontal cell population, highlighting its instructive capacity to promote this specific subtype
of inhibitory neurons. Finally, we also found that within bipolar cells, which are typically
glutamatergic interneurons, Ptf1a is able to trigger a GABAergic fate.
Conclusion: Altogether, our results reveal for the first time in the retina a major player in the
GABAergic versus glutamatergic cell specification genetic pathway.
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Background
Five classes of retinal neurons (photoreceptors, ganglion,
amacrine, horizontal and bipolar cells) and one type of
glial cells (Müller cells) are produced in a stereotypical
order from a multipotent pool of retinal progenitor cells
[1-4]. The conserved order of appearance during develop-
ment is thought to rely on the progenitor capacity to pass
through several intrinsically determined competence
states, during which they are capable of giving rise to only
a limited subset of cell types under the influence of extrin-
sic signals [5,6]. Previous studies have established that
these distinct retinal cell types are specified through a
combinatorial code of bHLH and homeodomain tran-
scription factors [5,7-9]. Importantly, these studies define
these transcription factors as cell type determining factors.
Behind the simplicity of the retina, encompassing only six
major cell types, lies a large diversity of retinal subtypes
forming a complex and subtle structure [10,11]. Mamma-
lian retinas contain approximately 55 distinct subtypes of
neurons, based on shape and arborization of these cells.
There are many reasons to believe that each of these cell
types has a distinct physiological function [10]. Indeed,
electrophysiological experiments have thus far revealed
specific functions for 22 morphological distinct subtypes.
A typical mammalian retina for example, contains ten to
fifteen subtypes of retinal ganglion cells and nine to
eleven subtypes of cone bipolar cells, based on their syn-
aptic inputs from cone photoreceptors and their sub-lam-
inar localization [10,12]. Amacrine cells, which modulate
synaptic activity between bipolar and ganglion cells, con-
stitute the most diverse cell type within the retina [10,11].
In mammals, they can be further classified into 29 differ-
ent amacrine subtypes based on criteria such as sub-lami-
nar localization (the inner plexiform layer, the ganglion
cell layer and the inner part of the inner nuclear layer),
morphology (e.g. starburst, parasol or midget) and neuro-
transmitter type (e.g. GABAergic, glycinergic, dopaminer-
gic or serotoninergic) [11]. In the anuran retina, the
number of amacrine subtype cells stands at no less than
21 [13].
The current step-wise model explaining how these multi-
ple subclasses of cells are specified, presages that retino-
genic factors first determine cell types, and that another
pool of transcription factors subsequently specifies retinal
neuronal subtypes [14]. Past work in developmental neu-
robiology has yielded significant insight into the molecu-
lar codes underlying the specification of the six major cell
classes. However, little attention has been paid to the
mechanisms sustaining the generation of the different
neuronal subclasses in the retina. For example, targeted
deletion studies have revealed that Vsx1, a paired-like
homeodomain factor, and Bhlhb4, an Olig-family bHLH
factor, are required for the development of cone bipolar
cell and rod bipolar cell subtypes, respectively. Notewor-
thy, phenotypic analysis revealed that these factors are not
involved in the determination of the cellular subtypes but
are rather required for their late differentiation [15-17].
Targeted deletion of Bhlhb5, an Olig family bHLH factor,
causes the loss of gamma-aminobutyric acid (GABA)-pro-
ducing amacrine and Type 2 OFF-cone bipolar cells. This
result, together with genetic interaction studies, argues for
a crucial role of Bhlhb5 in the specification of both ama-
crine and bipolar subtypes [18]. However, the transcrip-
tion factors responsible for the specification of the
majority of retinal subtypes remain to be identified.
For the most part, the molecular cues governing fate deter-
mination for the two most abundant neurotransmitter
phenotypes in the retina, GABA and glutamate, remain
unexplored. Several transcription factors have however
been reported as key players in this process within other
regions of the central nervous system. For instance,
ectopic expression of the homeobox gene Tlx3 is sufficient
to repress GABAergic differentiation and induce the for-
mation of glutamatergic cells in the spinal cord [19]. On
the other hand, the bHLH genes Mash1 and Heslike, and
the homeodomain genes Nkx2.1, Dlx1/2, and Gsh1/2 are
involved in the development of GABAergic neurons in the
telencephalon or spinal cord [20-24]. Recently, Ptf1a
(pancreas transcription factor 1a), a Twist subclass of
bHLH transcription factor, has been found to be involved
in driving neural precursors to differentiate into GABAer-
gic neurons in the cerebellum and in the dorsal horn of
the spinal cord [25-28]. In addition to the spinal cord,
hindbrain and cerebellum, Ptf1a is also expressed in the
retina during development [29-31]. Two reports studying
retinal explants of knock out mice suggest that Ptf1a is
involved in the genesis of horizontal and most amacrine
neurons, downstream of the forkhead transcription factor
Foxn4 [30,31]. Fujitani et al. indeed found that inactiva-
tion of Ptf1a results in a complete loss of horizontal cells,
a profound decrease of amacrine cells and an increase in
ganglion cells [30]. Nakkai et al. found that GABAergic
and glycinergic amacrine cells, as well as horizontal cells,
were completely missing in Ptf1a-knockout retinal
explants [31]. We further explored the retinal-specific
roles of Ptf1a, with an emphasis on neurotransmitter phe-
notypes, through the use of both gain and loss of function
analysis in Xenopus embryos. We found dramatic cell-
autonomous switches between GABAergic and glutama-
tergic neuron production, correlated with profound
defects in the genesis of amacrine and horizontal cells,
which are mainly GABAergic. Therefore, we investigated
whether Ptf1a determines the fate of these two cell types
or whether it acts directly as a GABAergic subtype deter-
mining factor. We found that in animal cap assays Ptf1a is
a potent GABAergic subtype inducer factor. In addition,
we showed that among a particular cell type, Ptf1a overex-BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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pression leads to an increased ratio of GABAergic subtype.
Together, this study reveals for the first time a key compo-
nent of GABAergic versus glutamatergic cell specification
genetic pathway in the retina.
Results
Ptf1a expression in the retina defines a subpopulation of 
precursor cells
The spatial and temporal distribution of Ptf1a transcripts
during Xenopus laevis retinogenesis was analyzed using
whole-mount  in situ hybridization (Fig. 1A–H). Ptf1a
expression was detected in the optic vesicle from stage 24/
25 onwards (not shown). In order to finely characterize
Ptf1a  expression in the neural retina, we sectioned
embryos transversely at key stages of retinogenesis. In the
proliferating neuroepithelium, Ptf1a displayed a patchy
expression pattern, with intense staining within discrete
groups of cells (Fig. 1J). As retinogenesis proceeds, stain-
ing progressively declined in the central retina while
remaining high in the margins, suggesting that Ptf1a
mRNA expression is turned off in differentiating cells and
exclusively maintained in precursor cells (Fig. 1K).
Accordingly, at stage 41, when all cells in the central retina
are post-mitotic, Ptf1a expression became restricted to the
ciliary marginal zone (CMZ), the only retinal region
where retinogenesis is still occurring post-embryonically
(Fig. 1L). Noticeably, Ptf1a-positive cells were not
detected in the most peripheral region of the CMZ, where
stem cells reside. Altogether, these data suggest that Ptf1a
mRNA is restricted to retinal precursors and features a sub-
population of retinoblasts, as inferred by its scattered dis-
tribution.
Pft1a cell-autonomously promotes amacrine and 
horizontal cell genesis
The Ptf1a expression profile led us to analyze whether it
might function in the context of Xenopus retinogenesis.
We first injected an inducible form of Ptf1a mRNA (Ptf1a-
GR) into two-cell stage embryos. Protein activity was
induced at stage 22 by addition of dexamethasone (DEX),
and effects on retinal cell type genesis were monitored
using specific markers. Ptf1a overexpressing retinas dis-
played substantial perturbations in laminar organization.
Expression of the horizontal marker Prox1 was strongly
increased following Ptf1a overexpression (Fig. 2A,B). Syn-
taxin staining of the inner plexiform layer (IPL) was
enhanced as well, suggesting a greater density of amacrine
cells (Fig. 2C,D). In contrast, highly reduced Brn3 expres-
sion (Fig. 2E,F) and virtual absence of rhodopsin staining
(Fig. 2G,H) indicated that ganglion cells and photorecep-
tors were profoundly missing. Expression of the bipolar
marker Vsx1, albeit disorganized, did not reveal any evi-
Ptf1a is expressed in a subpopulation of retinal precursors Figure 1
Ptf1a is expressed in a subpopulation of retinal precursors. Lateral (A-D) or dorsal (E-H) views of Xenopus embryos after Ptf1a 
whole-mount in situ hybridization at the indicated developmental stages. (A, E) Ptf1a-positive cells are detected in the presumptive hind-
brain (arrow) at stage 22. (B-D, F-H) At later tailbud stages, Ptf1a transcripts are detected in the retina (green arrowhead), the pancreas 
(black arrowhead) and the hindbrain (arrow). (I-L) As shown on retinal sections, Ptf1a starts to be expressed at late optic vesicle stages (I 
versus J), in a subpopulation of retinoblasts (spotty expression pattern in J). (K, L) Its expression progressively vanishes from the central 
retina as differentiation proceeds and is finally restricted to the CMZ (green arrowhead), although excluded from the stem cell containing 
region (red arrowhead). OpV: optic vesicle; CMZ: ciliary marginal zone; CR: central retina; L: lens. Scale Bars represents 300 μm (A-H) or 
50 μm (I-L).BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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dent reduction (Fig. 2I,J). Since Vsx1 is also expressed in
retinal precursors, the possibility remained that Vsx1-pos-
itive cells could be undifferentiated precursors dispersed
in the central retina. However, this was excluded, as the
expression of the precursor marker Xath5, was correctly
restricted to the CMZ (data not shown). Finally, cell death
was examined at stage 30, 35 and 39. The number of
apoptotic cells in Ptf1a overexpressing retinas did not dif-
fer from that of control embryos at any stage tested (data
not shown). Thus, Ptf1a gain of function drastically aug-
Ptf1a is required for proper amacrine and horizontal cell genesis Figure 2
Ptf1a is required for proper amacrine and horizontal cell genesis. (A-T) In situ hybridization (A-B, E-F, I-J, K-L, O-P, S-T) or 
immunofluorescence (C-D, G-H, M-N, Q-R) analysis of cell-type specific marker expression in stage 39/40 retinas, following Ptf1a-GR or 
Ptf1a Mo injection in two cell stage embryos. (A-J) Prox1 (horizontal marker, arrows in A and B) and syntaxin (optic nerve and inner plexi-
form layer marker, arrows in C and D) expressions are expanded in the central retina following Ptf1a overexpression. In contrast, both 
Brn3 (ganglion cell marker, arrows in E and F) and rhodopsin (photoreceptor marker, arrows in G, H) display highly diminished expres-
sion. Expression of Vsx1 (bipolar marker, arrows in I and J) does not show any clear decrease although significant disorganization is occa-
sionnaly observed in severe phenotypes (not shown). (K-T) Compared to control ones, Ptf1a Mo injected retinas display virtual absence 
of Prox1 expression (arrows in K, L) and reduced syntaxin staining in the IPL (arrows in M and N). Note the increased size of the optic 
nerve in Ptf1a knocked down retinas (arrowheads in M and N) that is consistent with the increased expression of the ganglion cell marker 
Brn3 (arrows in O and P). Both rhodopsin (arrows in Q and R) and Vsx1 (arrows in S and T) appear normally expressed albeit with a dis-
organized expression pattern. Ctrl: control; L: lens. Scale Bar represents 50 μm. (U-Y) Test of Ptf1a Morpholino efficiency. In vivo GFP flu-
orescence was analysed following co-injection of either Ptf1a Mo or Ctrl Mo with a chimeric GFP construct fused downstream Ptf1a Mo 
complementary region. (U) Schematic representation of the construct and sequences of Morpholino oligonucleotides. (V-Y) GFP expres-
sion can be observed in Ctrl Mo injected neurulas, while it is efficiently inhibited in Ptf1a Mo injected ones.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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ments horizontal and amacrine cell production at the
expense of photoreceptor and ganglion cells.
Parallel loss of function experiments were then performed
using an antisense Morpholino oligonucleotide designed
against the ATG-containing 5' end of Ptf1a (Ptf1a Mo; Fig.
2U–Y). Inhibition of Ptf1a resulted in complete loss of
Prox1-positive horizontal cells (Fig. 2K,L) and severe
decrease of syntaxin-stained amacrine fibers (Fig. 2M,N),
along with strong increase of the ganglion cell marker
Brn3 expression (Fig. 2O,P). Despite the significant lami-
nar disorganization, rhodopsin and Vsx1  stainings
revealed an apparent normal generation of photoreceptor
and bipolar cells, respectively (Fig. 2Q–T). In contrast to
the gain of function experiment, apoptosis was signifi-
cantly enhanced upon Ptf1a inhibition during retinogen-
esis (data not shown). These results indicate that at least
part of the Ptf1a knocked-down retinal precursors either
undergo apoptosis or are biased towards a ganglion fate at
the expense of amacrine and horizontal cell fates, simi-
larly to previous findings in mouse retina [30,31].
The above data suggest that Ptf1a is required for proper
generation of amacrine and horizontal cells. In order to
investigate whether Ptf1a acts cell autonomously, Ptf1a or
a Ptf1a chimeric construct fused to the VP16 transactiva-
tion domain (Ptf1a-VP16) were overexpressed in the
developing retina by in vivo lipofection at stage 17/18.
GFP expressing plasmid was used as a tracer, allowing for
the identification of transfected cells in stage 40/41
embryos, when most cells in the central retina are fully
differentiated [1]. Both Ptf1a constructs led to very similar
changes in cell type distribution, although Ptf1a-VP16
phenotype was clearly enhanced (Fig. 3A). In agreement
with two-cell stage injection experiments, Ptf1a overex-
pressing clones exhibited increased proportions of hori-
zontal and amacrine cells compared to control ones (Fig.
3A–E). This was, as expected, at the expense of photore-
ceptors and ganglion cells. Of note, although the global
proportion of cells in the ganglion cell layer was not
affected, ganglion cells were significantly depleted,
whereas displaced amacrine cells were drastically
increased (see below and Fig. 5D,K–P). Moreover, Müller
glial cells were virtually absent among Ptf1a-VP16 lipo-
fected clones. Altogether, these data suggest that Ptf1a acts
cell autonomously to bias precursor cells towards ama-
crine and horizontal destinies.
Ptf1a promotes a GABAergic cell fate of retinal precursor 
cells
Amacrine and horizontal interneurons have been
described in different model organisms as the two major
GABAergic populations in the retina, whereas photorecep-
tor, ganglion and bipolar cells are considered as mainly
glutamatergic [32]. As recent studies have highlighted a
role for Ptf1a in the specification of GABAergic neurons in
both the murine spinal cord [25] and cerebellum [26], we
wondered whether Ptf1a might have a similar function in
the retina. As expected, expression of glutamic acid decar-
boxylase (Gad), the rate limiting enzyme for GABA bio-
Ptf1a cell autonomously biases retinal precursors towards amacrine and horizontal cell fates Figure 3
Ptf1a cell autonomously biases retinal precursors towards amacrine and horizontal cell fates. Analysis of cell types distribu-
tion in stage 40/41 retinas, following Ptf1a or Ptf1a-VP16 lipofection. (A) Percentage of retinal cell types. Values are given as mean +/- 
s.e.m. p < 0.001 (***) (Student's t test). (B-E) Typical sections of retinas transfected with GFP alone (B, C) or GFP plus Ptf1a-VP16 (D, E), 
showing the dramatic increase of horizontal cells (arrows). C and E are higher magnifications of the dotted square delineated regions in B 
and D. Ctrl: control; L: lens; GC: ganglion cells; dAm: displaced amacrine cells; Bip: bipolar cells; Hor: horizontal cells; PH: photorecep-
tors; Mu: Müller cells. Scale Bar represents 50 μm.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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synthesis, was restricted to horizontal and amacrine cell
layers (Fig. 4A,G). Conversely, expression of VGlut1,
which encodes a glutamate transporter, could be detected
in photoreceptors, bipolar and ganglion cell layers (Fig.
4D,I). Ptf1a overexpression resulted in dramatic increase
of Gad staining in the retina (Fig. 4A–C) at the expense of
VGlut1 expression (Fig. 4D–F). In contrast, Ptf1a knocked-
down retinas exhibited severe to complete abrogation of
Gad-expressing cells (Fig. 4G,H), with concomitant
enlargement of the VGlut1-expressing domain (Fig. 4I,J).
Such phenotypes are consistent with the above cell type
distribution data and thus raise the question of whether
Ptf1a determines the fate of cell types that are mainly
GABAergic or whether it directly acts as a GABAergic sub-
type determination factor. To further explore this second
hypothesis, we tested the capacity of Ptf1a to activate Gad
expression in ectodermal explants (animal caps). Similar
to X-ngnr-1, Ptf1a was able to induce neurogenesis in
naive animal caps, as shown by N-tubulin  expression.
Importantly, overexpression of Ptf1a, but not that of X-
ngnr-1, resulted in a significant induction of Gad expres-
sion (Fig. 4K). On the other hand, X-ngnr-1 but not Ptf1a,
strongly activated the expression of XHox11L2/Tlx3, a
selector gene determining glutamatergic over GABAergic
cell fates in the spinal cord [19] (Fig. 4K). In whole
Ptf1a misexpression dramatically affects the ratio of GABAergic versus glutamatergic neurons Figure 4
Ptf1a misexpression dramatically affects the ratio of GABAergic versus glutamatergic neurons. (A-J) In situ hybridization 
analysis of glutamic acid decarboxylase (Gad) and glutamate transporter 1 (Vglut1) in stage 39/40 retinas, following Ptf1a-GR or Ptf1a Mo 
injection in two-cell stage embryos. (A-F) Ptf1a overexpression results in a drastic increase of Gad staining (A-C) at the expense of VGlut1 
staining (D-F). Shown in C and F are strong phenotypes compared to milder ones in B and E. (G-J) Conversely, Ptf1a knocked-down ret-
inas display virtual absence of Gad expression (G, H), while that of VGlut1 is highly expanded (I, J). Arrow and arrowhead in A and G point 
to Gad expression domain in amacrine and horizontal layers, respectively. Black arrow, white arrow and black arrowhead in D and I point 
to VGlut1 expression domain in ganglion, bipolar and photoreceptor cells, respectively. Ctrl: control; L: lens; NT: neural tube. Scale Bar 
represents 50 μm. (K) Real-time RT-PCR analysis of Gad and Hox11L2 expression in animal cap assays (equivalent stage 16), following X-
ngnr-1-GR (25 pg) or Ptf1a-GR (50 pg) overexpression. N-tubulin was used as a control for X-ngnr-1 and Ptf1a neuralizing activities. Expres-
sion levels were normalized to ornithine decarboxylase (ODC). The expression levels were measured using a standard curve for each ana-
lyzed gene. All measurements were done in duplicates and the values in the figures represent the mean of a representative experiment. 
(L-Q) In situ hybridization analysis of N-tubulin (N-tub) and Gad expression in whole embryos (stage 28 in L-N and 24 in O-Q), following X-
ngnr-1 or Ptf1a mRNA injection in one of two blastomere of two-cell stage embryos. (R, S) In situ hybridization analysis of Gad expression 
in the neural tube (stage 28), following Ptf1a-GR or Ptf1a Mo injection in one of two blastomere of two-cell stage embryos. The Ptf1a-GR 
injected embryos were induced with dexamethasone at stage 11. NT: neural tube; NC: notocord; inj: injected side. Scale Bar represents 
100 μm.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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embryos, Ptf1a still behaved as a proneural gene, induc-
ing, as X-ngnr-1, ectopic N-tubulin expression in the epi-
dermis (Fig. 4L–N). However, only Ptf1a was able to drive
Gad ectopic expression (Fig. 4O–Q). Finally, in the neural
tube, the Gad  expression domain was substantially
extended in Ptf1a-injected embryos (Fig. 4R). Conversely,
injection of Ptf1a Mo strongly reduced Gad expression in
the hindbrain (Fig. 4S). These results demonstrate that
Ptf1a can act as a GABAergic subtype inducing factor and
suggest that it is specifically required in the retina for
GABAergic cell genesis at the expense of glutamatergic
neurons.
Ptf1a differentially affects subtypes of amacrine and 
horizontal neurons
In order to demonstrate that Ptf1a does not simply specify
amacrine and horizontal cell fates but rather specifically
pushes retinal precursors to adopt a GABAergic pheno-
type, we analyzed the proportion of GABA-positive cells
within horizontal and amacrine Ptf1a-overexpressing
cells, through a clonal analysis. We found that the ratio of
GABAergic neurons in both cell types was largely
increased compared to controls (Fig. 5A–P). Noticeably,
regarding amacrine cells, this increase was essentially due
to a dramatically enhanced proportion of GABA-positive
displaced amacrine cells (Fig. 5B–D,K–P). This result sug-
gests that Ptf1a has the particular function of differentially
favoring GABAergic subtypes among amacrine and hori-
zontal cells.
We next examined whether other neurotransmitter sub-
types of amacrine cells were affected following Ptf1a
misexpression. Injection experiments revealed that the
number of serotoninergic (serotonin-immunoreactive)
Ptf1a overexpression leads to enhanced proportions of GABAergic horizontal and displaced amacrine cells Figure 5
Ptf1a overexpression leads to enhanced proportions of GABAergic horizontal and displaced amacrine cells. Analysis of 
GABAergic cell proportions among GFP-positive horizontal and amacrine transfected cells in stage 40/41 retinas, following Ptf1a-VP16 
lipofection. (A-D) Quantification of GABA-positive cells in the horizontal, amacrine and ganglion cell layers as indicated. Values are given 
as mean +/- s.e.m. p < 0.001 (***) (binomial test). (E-P) Typical sections of retinas lipofected with gap-GFP alone (E-G, K-M) or gap-GFP 
plus Ptf1a-VP16 (H-J, N-P), immunostained with an anti-GABA antibody. Arrows in E-G and K-M point to examples of gap-GFP-transfected 
GABA-negative horizontal and ganglion cell, respectively, in control retinas. Arrows in H-J and N-P point to GABA-positive horizontal 
and displaced amacrine cells, respectively, in gap-GFP plus Ptf1a-VP16 lipofected retinas. Ctrl: control; HCL: horizontal cell layer; ACL: 
amacrine cell layer; GCL: ganglion cell layer; INL: inner nuclear layer. Scale Bar represents 30 μm.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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and dopaminergic (tyrosine hydroxylase-immunoreac-
tive) amacrine cells were, like GABAergic ones, decreased
following Ptf1a loss of function and increased upon over-
expression (Fig. 6A–R). We also found that the number of
glycine-positive cells was significantly lower in the retina
of Ptf1a Mo-injected embryos (Fig. 6S,T,W). Surprisingly,
however, in Ptf1a overexpressing retinas, a severe decrease
of glycinergic amacrine cells could be observed (Fig.
6U,V,X). To rule out potential secondary effects resulting
from impaired retinal morphogenesis, we turned to clonal
analysis through in vivo lipofection. In contrast to the
Ptf1a  two-cell stage injection data, Ptf1a-VP16  overex-
pressing clones displayed a significant increase in the pro-
portion of glycine-positive amacrine cells (50% n = 4
retinas, 176 cells versus 33% n = 5 retinas, 185 cells; p <
0.001). Thus, Ptf1a seems to be able, at least in some con-
ditions, to favor glycinergic, dopaminergic, and serot-
onin-positive cell genesis, at the expense of yet
unindentified other amacrine subtypes.
Ptf1a converts glutamatergic bipolar interneurons into 
GABAergic cells
In contrast to glutamatergic photoreceptors and ganglion
cells that are extensively suppressed upon Ptf1a overex-
pression, bipolar cells appear largely unaffected both in
two-cell stage injection and lipofection experiments (Fig.
1I–J and Fig. 3A). Regarding the global reduction of
VGlut1 staining in Ptf1a-GR injected retinas (Fig. 4D–F), it
is likely that a significant proportion of bipolar cells must
have altered its fate towards another neurotransmitter
phenotype. The existence, in physiological conditions, of
a minority GABAergic bipolar subpopulation in amphibi-
ans [33,34] led us to postulate that Ptf1a gain of function
might drive bipolar precursors to acquire a GABAergic
phenotype. As a first attempt to test this hypothesis, we
performed double in situ hybridizations using the Vsx1
bipolar probe in combination with either the VGlut1 or
Gad probes. As expected, Vsx1 staining appears to be co-
localized with the VGlut1-positive layer of the INL but not
with the Gad-positive one in control embryos (Fig. 7A,C).
In contrast, in Ptf1a overexpressing retinas, double Vsx1/
Vglut1  staining was highly reduced (Fig. 7B), while
regions co-expressing both Vsx1 and Gad were apparent
Ptf1a misexpression differentially affects amacrine cell subtypes genesis Figure 6
Ptf1a misexpression differentially affects amacrine cell subtypes genesis. Quantification of GABA-, serotonin (5-HT)-, tyrosine 
hydroxylase (TH)- and glycine-positive cells, following Ptf1a Mo (stage 40/41) or Ptf1a-GR (stage 39, except in O, P, R stage 41) injection 
in two cell stage embryos. (A-D, G-J, M-P, S-V) Typical sections of control, Ptf1a knocked-down or Ptf1a overexpressing retinas, immu-
nostained for GABA, 5-HT, TH or glycine (arrows) as indicated. Graphs indicate the average numbers of GABA-, 5-TH-, TH- or glycine-
positive cells per retinal section in each condition. Values are given as mean +/- s.e.m. p < 0.001 (***), p < 0.05 (*) (Student's t test). Ctrl: 
control; L: lens. Scale Bar represents 50 μm.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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(Fig. 7D), suggesting that some glutamatergic bipolar cells
transfated towards a GABAergic phenotype. This result
could be further assessed through clonal lipofection anal-
ysis (Fig. 7E–K). Indeed, we observed a dramatic increase
in the proportion of GABA-positive cells among Ptf1a-
lipofected cells localized in the bipolar cell layer com-
pared to control ones (43% versus 5%).
It has recently been shown that the Otx2 transcription fac-
tor, which is selectively expressed in a subpopulation of
bipolar cells [35], controls identity and fate of glutamater-
Ptf1a overexpression triggers the conversion of glutamatergic bipolar interneurons into GABAergic cells Figure 7
Ptf1a overexpression triggers the conversion of glutamatergic bipolar interneurons into GABAergic cells. (A-D) Double in 
situ hybridization analysis of Vsx1/VGlut1 or Vsx1/Gad co-expression (stage 39/40), following Ptf1a-GR injection in both blastomeres of two 
cell stage embryos. (A) In control retinas, VGlut1 stains ganglion (black arrow) and photoreceptor cells (black arrowhead) and colocalizes 
with Vsx1 in bipolar cells (white arrow). (B) Double VGlut1/Vsx1 staining is highly reduced in Ptf1a overexpressing retinas (white arrow: 
region of double staining persistence, red arrow: Vsx1-positive region with no VGlut1 staining). (C) Gad (white arrow) and Vsx1 (black 
arrow) have exclusive expression patterns in control retinas. (D) Upon Ptf1a overexpression, regions of double Gad/Vsx1 staining become 
apparent (arrow). (E-K) Analysis of GABAergic bipolar cell proportion in stage 40/41 retinas, following Ptf1a-VP16 lipofection. (E-J) Typi-
cal sections of retinas transfected with gap-GFP alone (E-G) or gap-GFP plus Ptf1a-VP16 (H-J), immunostained with an anti-GABA antibody. 
Arrows point to a transfected GABA-negative bipolar cell in a control retina (E-G) and to a GABA-positive one in Ptf1a-VP16 overex-
pressing retina (H-J). (K) Quantification of GABA-positive bipolar cells among transfected cells. (L-N) Immunofluorescence analysis of 
Otx2 expression (stage 39), following Ptf1a-GR injection in one of two blastomere of two cell stage embryos. (L, M) Typical sections of 
control (L) and Ptf1a overexpressing (M) retinas immunostained for Otx2 (arrow). (N) Quantification of Otx2-positive cells per retinal 
section in each condition. (O-W) Analysis of Otx2-positive bipolar cell proportion in stage 40/41 retinas, following Ptf1a-VP16 lipofection. 
(O, V) Typical sections of retinas transfected with GFP alone (O-R) or GFP plus Ptf1a-VP16 (S-V), immunostained with an anti-Otx2 anti-
body. (P-R) and (T-V) are higher magnifications of the delineated regions in O and S, respectively. Arrows point to transfected Otx2-pos-
itive bipolar cells in a control retina (P-R) and Otx2-negative ones in Ptf1a-VP16 overexpressing retina (P-R). (W) Quantification of Otx2-
positive bipolar cells among transfected cells. Values are given as mean +/- s.e.m. p < 0.001 (***)(Student's t test in N, binomial test in K 
and W). Ctrl: control; L: lens; INL: inner nuclear layer; GCL: ganglion cell layer. Scale Bar represents 50 μm in A-D, L, M and 30 in E-J, O-
V.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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gic progenitors of the thalamus by repressing the alterna-
tive GABAergic differentiation program [36]. We thus
wondered whether the capacity of Ptf1a to force GABAer-
gic fate of bipolar cells might be related to effects on Otx2
expression. Ptf1a-GR injection in two-cell stage embryos
indeed led to a drastic reduction of Otx2-positive cells in
the outer portion of the INL (Fig. 7L–N). Consistently,
clonal analysis revealed a decreased proportion of Otx2-
positive cells among Ptf1a-overexpressing bipolar cells
compared to a control experiment (7% versus 27%, Fig.
7O–W). Thus, Ptf1a overexpression leads to an unbalance
between GABA and Otx2-positive bipolar cell subtypes.
Discussion
Many transcription factors affect the diversity and num-
bers of distinct retinal cell types. In contrast, studies iden-
tifying molecular cues underlying retinal subtype
specification are limited. We focused our attention on
GABAergic inhibitory neurons and glutamatergic excita-
tory neurons. In the central nervous system, a balance of
excitation and inhibition is essential for nearly all func-
tions, and imbalances can result in sensory disorders. In
the retina, the complex network of excitatory and inhibi-
tory pathways contributes to edge sharpening, contrast
enhancement, spatial summation, noise averaging, and
other forms of signal processing. Thus far, the molecular
players governing the determination of glutamatergic and
GABAergic neurons in the retina have surprisingly
remained unexplored. We report here on the key role of
Ptf1a in this process. To reach this conclusion, the role of
Ptf1a during retinogenesis was examined using both gain
and loss of function approaches through different experi-
mental strategies, including histological assessment of ret-
inal cell types and subtypes, clonal analysis and animal
cap assays.
The role of Ptf1a in the retina has been studied through its
inactivation in mice and analyzed in retinal explants
[30,31]; it led to a complete loss of horizontal cells and to
a profound decrease of amacrine cells, suggesting that
Ptf1a plays a central role in directing retinal progenitors
towards these cell fates. In our loss of function analyses in
the Xenopus retina, we confirmed a severe reduction of
amacrine and horizontal cells. As reported in Ptf1a-/- reti-
nal explants, we also observed a concomitant increase of
ganglion cells. Our gain of function results reinforce the
idea that Ptf1a is able to bias retinal precursors towards
amacrine and horizontal fates. However, Nakkai et al.
found that in the Ptf1a null retina a small number of ama-
crine precursor cells differentiated to amacrine cells and
thus proposed that Ptf1a may contribute to the specifica-
tion of amacrine cell subtypes rather than to the genera-
tion of whole amacrine cells [31]. Indeed, as discussed
below, our detailed analysis of the neuronal subtype dis-
tribution in both gain and loss of function experiments,
revealed that Ptf1a may play a role in neurotransmitter
subtype specification rather than simply specifying ama-
crine and horizontal cell fates.
Past work has identified Ptf1a as the responsible gene for
permanent neonatal diabetes mellitus associated with
pancreatic and cerebellar agenesis [37]. The function of
Ptf1a in the cerebellum has been investigated in cerebel-
less mutant mice and revealed its role in defining GABAer-
gic neuronal fates [26]. In addition, involvement of Ptf1a
in the genetic cascade specifying GABAergic over glutama-
tergic neurons has been established in the dorsal spinal
cord [25]. Our GABA and glutamate analysis support the
hypothesis that Ptf1a also promotes a switch between
GABAergic and glutamatergic fates in the retina. Through
clonal analysis, we further demonstrated the instructive
capacity of Ptf1a to trigger GABAergic neuron production
within amacrine and horizontal cell populations. We thus
propose that Ptf1a does not simply determine horizontal
and amacrine interneurons but preferentially promotes
formation of the GABAergic subtypes of these cells. It is
likely that Ptf1a truly acts as a determining factor rather
than a differentiation factor, as we found that it is suffi-
cient to drive neuronal differentiation in both ectodermal
explants and whole embryos and has the ability to change
precursor fate in the retina.
Noticeably, we also found that serotoninergic and
dopaminergic amacrine cells, two minority subtypes, were
increased upon Ptf1a overexpression and decreased upon
Ptf1a loss of function. Ptf1a may be directly required for
the specification of these subtypes. Importantly, however,
evidence for a dual expression of GABA and serotonin or
GABA and dopamine has been reported in the retina of
several species including Xenopus [38-41]. Hence, an
alternative hypothesis is that Ptf1a-induced changes in the
number of GABAergic cells account for the observed
effects on the amount of 5-HT- and TH-positive neurons.
As observed in mice [30,31], we also found that glyciner-
gic amacrine cell genesis was inhibited upon Ptf1a loss of
function. However, a potential role of Ptf1a in determin-
ing this cell subtype remains unclear regarding our gain of
function experiments. Indeed, we obtained opposite phe-
notypes when Ptf1a was either overexpressed following
retinoblast  in vivo lipofection (increase) or by two-cell
stage mRNA injections (decrease). Such a discrepancy
may arise from differences in dose and/or timing of Ptf1a
transgene expression. As feedback loops are known to reg-
ulate amacrine cell genesis [42], the possibility also
remains that the dramatic perturbation of the GABAergic
cell population, as observed in the two cell stage injection
experiments, may non cell-autonomously affect glyciner-
gic cell production.BMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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Using retrograde neuronal tracer experiments, it has been
established that some ganglion cells in the outer half of
the ganglion cell layer are GABA-positive [43]. We thus
wondered whether some of the numerous GABAergic cells
found in the ganglion cell layer upon Ptf1a overexpression
might actually be ganglion cells rather than displaced
amacrine cells. Our GAP-GFP (a membrane bound GFP
allowing to better stain neuronal fibers) staining high-
lighted that a few of these cells have processes resembling
ganglion cell axons (data not shown), while displaced
amacrine cells have neurites oriented towards the INL
[44]. Thus, although this situation remains to be quanti-
fied with a more accurate technical approach, we suspect
that Ptf1a, in addition to increase the proportion of
GABAergic displaced amacrine cells in the ganglion cell
layer, may also increase the proportion of GABA-positive
ganglion cells.
Even though retinal bipolar neurons mainly release the
excitatory transmitter glutamate, evidence that certain
bipolar cells contain GABA and express Gad  has been
reported in both mammalian and amphibian retinas
[33,34,45,46]. Both our double in situ experiments and
clonal analysis revealed that, in a context of Ptf1a overex-
pression, a considerable proportion of bipolar neurons
transfate towards a GABAergic phenotype. Genetic lineage
tracing in mice did not reveal that some Ptf1a-expressing
precursors are dedicated to bipolar cell production. How-
ever, the low number of GABAergic bipolar neurons in
wild type retinas may have hindered the identification of
a Ptf1a-positive bipolar lineage. Therefore, although this
deserves further investigation, our data suggest that Ptf1a
may have a role in specifying the GABAergic bipolar sub-
type. Altogether, these findings indicate that Ptf1a can act
as a neuronal subtype determination factor, which
instructs neural precursors to differentiate into GABAergic
neurons. Our findings thus suggest that Ptf1a constitutes
the first identified member of the genetic cascade respon-
sible for GABAergic cell specification in the retina.
Several in vitro studies suggest that, in the optic vesicle,
some retinal progenitors are not multipotent but are
instead differentially biased towards specific cell types,
such as rod and bipolar cells or amacrine and horizontal
cells for instance [42,47-49]. Molecular identification of
these precursor subpopulations is largely lacking. The
transcription factor FoxN4 is expressed in a restricted sub-
set of retinal precursors and presumably confers the com-
petence to form amacrine and horizontal cells [50]. Ptf1a
also labels a subpopulation of retinoblasts at both the lev-
els of mRNA (this study) and protein expression [30,31].
Our data suggest that Ptf1a-expressing precursors are
biased towards a GABAergic fate. As we showed that Ptf1a
mRNA starts to be detectable in discrete groups of prolif-
erating precursors as soon as the optic vesicle forms, it is
likely that the segregation of a population fated to the
GABAergic subtype occurs early in retinal development.
This does not fit with the step-wise model supporting the
view that subtype specification follows cell class determi-
nation. For instance, in the mouse retina it has been pro-
posed that pan-bipolar cells are first specified by Chx10,
Math3 and Mash1 and that specification of OFF and ON
cone subtypes takes place subsequently under the influ-
ence of another set of transcription factors [15]. However,
our hypothesis that GABAergic fate specification occurs
early in retinogenesis is substantiated by several lineage
and transplantation experiments demonstrating that
some blastomeres are intrinsically biased, as early as dur-
ing the early cleavage stage, to produce subsets of neuro-
transmitter subtypes of amacrine cells [49,51]. Moreover,
it has recently been reported that Rx1 and Pax6 misexpres-
sion at the eye field stage differentially affects amacrine
subtypes proportions, suggesting that these interneurons
are not all specified by a single genetic program [52].
Together with our present work, these findings support
the hypothesis that at least some neurotransmitter sub-
types are specified by a combinatorial code of transcrip-
tion factors during early eye development. Importantly,
we were able to highlight a role of Ptf1a in GABAergic neu-
ron specification as we analyzed various subtypes of reti-
nal cells. In this regard, it is likely that other transcription
factors, described so far as cell type inducers, may actually
have a role in the formation of different retinal neuro-
transmitter subtypes. It would therefore be important to
re-evaluate the effects of key components of retinal cell
fate specification in the context of cell subtype determina-
tion. Such future work would be critical to understand the
molecular events that generate the myriad of different cell
subtypes in the retina.
Conclusion
Altogether, our gain and loss of function data identify
Ptf1a as a determining factor for retinal GABAergic sub-
types neurons as opposed to a determining factor for cell
types. Further work examining neurotransmitter cell sub-
types should expand our knowledge about retinogenesis,
and permit in particular to uncover the genetic network
sustaining GABAergic/glutamatergic determination in the
retina.
Methods
Constructs and Morpholinos
pCS2+-X-ngnr-1,  pCS2+-X-ngnr-1-GR  [53],  pCS2+-Ptf1a
and pCS2+-Ptf1a-GR [29] have previously been described.
X-ngnr-1-GR and Ptf1a-GR encode glucocorticoid induci-
ble chimeric morphants. Protein activity was induced
with 4 μg/ml dexamethasone (DEX, Sigma) in the embryo
medium. The pCS2+-Ptf1a-VP16 encodes a Ptf1a variant
where the VP16 transactivation domain is fused to the car-
boxylterminus of Ptf1a. The Ptf1a (Ptf1a Mo; [29]) andBMC Developmental Biology 2007, 7:110 http://www.biomedcentral.com/1471-213X/7/110
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control (Ctrl Mo, 5 mismatches; Fig. 2U) Morpholino
(Mo) oligonucleotides were purchased from GeneTools
(LLC). Two types of Mo were used: crude Mo (for blast-
omere injection experiments), and "Special Delivery" Mo,
where the non-ionic crude Morpholinos are paired to a
complementary carrier DNA (for lipofection experiments)
[54,55]. The region complementary to the Ptf1a  Mo
(encompassing 5' untranslated and N-terminal-coding
regions of Ptf1a) was amplified by PCR from pBK-CMV
Ptf1a and cloned in frame downstream of the GFP coding
sequence in pCS2 plasmid (pCS2+-Ptf1a(5')-GFP; Fig.
2U).
Embryos, microinjections and animal cap explants
Xenopus laevis embryos were obtained by hormone-
induced egg laying and in vitro fertilization by conven-
tional methods. Capped sense RNAs were prepared from
CS2 plasmids after NotI digestion and transcribed using
the mMessage mMachine™ SP6 kit (Ambion). RNAs were
injected in a volume of 5 nl at a concentration of 100–150
pg/nl into two of two or one of two blastomeres of
embryos at the two-cell stage. GFP RNA (100 pg) co-injec-
tion was used to visualize injected cells. Morpholino (Mo)
injections were performed as indicated by the manufac-
turer (GeneTools, LLC). Animal cap explants and real-
time RT-PCR analysis were performed as previously
described [56]. The following primers pairs were used:
ODC [57]; N-tubulin [58]; Gad for: ATGGGCGTCT-
TACTCCAATG, rev: ATGTCTACATGGCGACCACCACA;
Hox11L2 for: GCCAACAAGTACAAGTGCACAG, rev:
CAGGAGCCAGACTCACATTGAC.
In vivo lipofection
pCS2-GFP, pCS2-Ptf1a and pCS2-Ptf1a-VP16 were trans-
fected at stage 18 into the presumptive region of the retina
as previously described [55,59]. Embryos were fixed at
stage 40/41 and cryostat sectioned (12 μm). GFP-positive
cells were counted and cell types were identified based
upon their laminar position and morphology [60]. In
some cases, the gap-GFP plasmid (a gift from E. Amaya),
which encodes a membrane bound GFP, was used to
improve neuronal fiber staining in order to better assess
retinal cell type identity.
Immunohistochemistry and Tunnel assay
Immunohistochemistry was performed as described pre-
viously [61], using rabbit polyclonal or mouse mono-
clonal anti-GFP (Molecular Probe), rabbit polyclonal
anti-GABA (ImmunoStar), rabbit polyclonal anti-Glycine
(ImmunoSolution), rabbit polyclonal anti-serotonin
(Immunostar), mouse monoclonal anti-tyrosine hydroxy-
lase (Immunostar), mouse monoclonal anti-syntaxin
(Sigma), rabbit polyclonal anti-Otx2 [35], mouse mono-
clonal anti-rhodopsin (clone R2–12, a gift from N. Col-
ley), and anti-mouse or anti-rabbit fluorescent secondary
antibodies (Alexa, Molecular Probes). Cell nuclei were
counterstained with Hoechst (Sigma). Detection of cell
apoptosis was carried out with the DeadEnd fluorometric
TUNEL system (Promega). Fluorescent stainings were vis-
ualized with a Leica HBO100 microscope. Images were
then captured using a QICAM camera (QIMAGING) and
processed with Adobe Photoshop 7.0 software. Shown in
figures are representative data from one experiment that
has been performed at least in duplicate.
In situ hybridization
Digoxigenin- or fluorescein-labelled antisense RNA
probes, Ptf1a [29], Gad [62], XVGlut1 [62], XVsx1  [63],
Brn3.0  [64], Prox1 (a gift from F. Cremisi) and Xath5  [65]
were generated according to the manufacturer's instruc-
tions (Roche). Whole mount in situ hybridization was car-
ried out as previously described [66], with an additional
step of bleaching just before the proteinase K treatment
[67]. For double in situ hybridization, XVsx1 fluorescein-
labeled probes were first revealed with Fast red substrate
(Roche). Embryos were then treated in 0.1 M Glycine-HCl
pH 2.2 for 10 minutes and processed for Gad or XVGlut1
digoxigenin-labeled probe revelation using NBT/BCIP.
Embryos were then vibratome sectioned (50 μm).
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